Adelaide is recognised as a centre of excellence for bioscience.
Having built a reputation for scientific and medical research, South Australia has much to offer potential investors, including:
- A history of successfully commercialising university research
- Development and creation of spin-off companies
- A low cost-base.
Adelaide is Australia’s most cost-competitive city for biomedical research and developments and clinical trials, as ranked by KPMG’s Competitive Alternatives 2010.
BioSA, an initiative of the South Australian Government, is dedicated to fostering the growth of the South Australian bioscience industry through the provision of:
Since BioSA’s establishment in 2001, bioscience company numbers in South Australia have more than doubled and venture capital investment has increased significantly.
BioSA is committed to promoting and accelerating the commercialisation of R&D in South Australia, and has a purpose-built business incubator located in the heart of the Thebarton Technology Cluster. The incubator is currently home to a diverse mix of early stage bioscience companies, operating in sectors such as: medical devices, diagnostics and environmental technology, and is a key contributor to the growing South Australian technology industry.